Press Releases

Date Description  
Jul 26, 2017
Cogentix Medical Acquires Genesis Medical; Transaction to Further Increase Urology Products Revenue Growth Rate
MINNEAPOLIS , July 26, 2017 /PRNewswire/ --  Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company focused on providing the Urology, Uro/Gyn and Gynecology markets with innovative and proprietary products, today announced that it has acquired privately held Genesis Medical based in
Jul 20, 2017
Cogentix Medical to Report Second Quarter Results on August 1, 2017
MINNEAPOLIS , July 20, 2017 /PRNewswire/ --  Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company focused on providing the Urology, Uro/Gyn and Gynecology markets with innovative and proprietary products, will release financial results for the second quarter ended June 30, 2017
Jul 18, 2017
Cogentix Medical Signs Agreement to Launch Endo-Urology Product Line in US; Launch to Further Increase Urology Products Growth Rate During 2018
MINNEAPOLIS , July 18, 2017 /PRNewswire/ --  Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company focused on providing the Urology, Uro/Gyn and Gynecology markets with innovative and proprietary products, today announced that it has entered into an exclusive license with Promepla,
May 2, 2017
Cogentix Medical Reports First Quarter Operating Results; Urology Revenue Up 11 Percent

Conference Call Today at 4:30 p.m. ET

Apr 20, 2017
Ash Keswani Joins Cogentix Medical as SVP of Marketing and Business Development
MINNEAPOLIS , April 20, 2017 /PRNewswire/ --  Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company focused on providing the Urology, Uro/Gyn and Gynecology markets with innovative and proprietary products, today reported that Ash Keswani has joined the Company as Senior Vice
Apr 18, 2017
Cogentix Medical to Report First Quarter Results on May 2, 2017
MINNEAPOLIS , April 18, 2017 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company focused on providing the Urology, Uro/Gyn and Gynecology markets with innovative and proprietary products, will release financial results for the first quarter ended March 31, 2017
Mar 9, 2017
Cogentix Medical Reports Strong Fourth Quarter Operating Results

Q4 Represents Fifth Consecutive Quarter of Cash Operating Profit<br>Conference Call Today at 11:00a ET

Mar 6, 2017
Cogentix Medical to Participate in the 29th Annual ROTH Conference
MINNEAPOLIS , March 6, 2017 /PRNewswire/ --  Cogentix Medical, Inc.  (NASDAQ: CGNT), a medical device company that develops, manufactures and markets innovative proprietary products for the urology market, today announced that the Company will participate in the 29th Annual ROTH Conference on
Feb 23, 2017
Cogentix Medical to Report Fourth Quarter Results on March 9, 2017
MINNEAPOLIS , Feb. 23, 2017 /PRNewswire/ --  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company that develops, manufactures and markets innovative proprietary products for the urology market, will release financial results for the fourth quarter and fiscal year ended December 31, 2016
Nov 8, 2016
Cogentix Medical Reports 13 Percent Q3 Revenue Growth

Fourth Consecutive Quarter of Cash Operating Profit<br>Shareholders Approve Proposals to Convert Debt and $25 Million Equity Purchase Agreement<br>Company Now Debt-Free with Additional Resources to Execute Growth Strategies<br>Conference Call Today at 4:30 pm ET

Displaying 11 - 20 of 74